What I am most excited about is:
Bile tract cancer expansion trial opened and is expected to enroll approximately 10
patients; preliminary early data is expected in the second half 2024. - appreciate them giving us a timeline for data release!
That's what we have FDA fast track status for.
Given the sale of the facility (which I think was financially responsible), this should set us up to be well into 2025 prior to a CR (or deal with BP). Who knows what results we will have tabled by then...
Go you good thing.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-24
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $409.9M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.6¢ | $726.3K | 12.72M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 607456 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 714507 | 13 |
View Market Depth
| Last trade - 11.50am 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.8¢ |
Change
0.000 ( 1.03 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.8¢ | 5.6¢ | 3901098 | ||
| Last updated 12.32pm 14/06/2024 ? | |||||
| IMU (ASX) Chart |